ServiceXS Introduces new Line of Products and Services based on DNAFORM’s Cloning and CAGE Technology
News Oct 06, 2008
DNAFORM and ServiceXS B.V. have announced that the companies signed an agreement in which ServiceXS is appointed as exclusive distributor for DNAFORM’s products and services using DNAFORM’s proprietary cloning and CAGE technology in the Benelux.
On October 1st, ServiceXS officially launched two new services: DeepCAGE and NormRNA sequencing. DeepCAGE, a combination of DNAFORM’s proprietary CAGE technology® and ServiceXS’ next-generation sequencing service, facilitates genome-wide analysis of 5’-ends of mRNA molecules.
Currently, DeepCAGE allows sequencing of 5 million 5’ RNA-ends in a single run. DeepCAGE offers a solution to study transcription initiation and regulation at a whole-genome level. Furthermore, DeepCAGE enables promoter mapping.
The NormRNA sequencing service combines DNAFORM’s technology to create full-length, normalized cDNA Libraries with ServiceXS’ next-generation sequencing service, enabling genome-wide analysis of the transcriptome.
Applications include whole transcript profiling in basic genome projects, analysis of RNA splice variants in fundamental research, as well as a wide range of specialized applications like the discovery of new RNA-RNA fusions in oncology research. In addition, DNAFORM full-length cDNA libraries provide access to cDNA clones for newly discovered transcripts for further functional analysis.
Researchers Awarded $28M for Illuminating Druggable Genome NIH GrantsNews
Researchers receive grants as part of the NIH program focused on experimental and informatics approaches to characterize understudied proteins from three gene families: ion channels, G protein-coupled receptors (GPCRs), and protein kinases.READ MORE
No Country for Old GenesNews
Our modern world is radically different from the one we evolved in, and that creates a mismatch between the environment our genes were evolved to face, and the world those genes now encounter. A new review looks at how certain genes that benefited humans in our genetic past now predispose us to disease in old age.READ MORE
CRISPR Editing Stops HIV Virus in Infected CellsNews
Human immunodeficiency virus-1 (HIV-1) infection is a chronic disease affecting more than 35 million people worldwide. The infection can be controlled by antiretroviral therapy (ART), but there is still no complete cure. Now, a new study targeting the regulatory genes of the virus using CRISPR/Cas9 has helped block the production of the virus by infected cells.READ MORE